beta-interferon


Also found in: Dictionary, Thesaurus, Acronyms.
Related to beta-interferon: Interferon beta-1a

beta-interferon

n.
A family of glycoproteins that are produced by fibroblasts, have antiviral properties, and are used in the treatment of multiple sclerosis.
References in periodicals archive ?
The guidelines for beta-interferon treatment for relapsing-remitting MS state that a person must be over 18, mobile and not pregnant.
A spokesman for the Department of Health said: 'It is because of the variations in prescribing beta-interferon that the government referred it to NICE.
Another postdoctoral scholar in the Steinman lab, Brigit deJong, MD, the study's second author, had previously been involved in research in Amsterdam in which multiple-sclerosis patients were treated with beta-interferon and meticulously followed up.
She said although she could not use beta-interferon herself, barring the drug would take away the incentive for further research into drugs for different strands of MS.
To date, Aegis has licensed Intravail(TM) for beta-interferon, low molecular weight heparin, and for up to three undisclosed pediatric drugs.
to include beta-interferon and low molecular weight heparin and has since initiated feasibility studies on a growing number of additional peptide and protein therapeutics for several pharmaceutical clients.
ITI") and Aegis Therapeutics ("Aegis") today announced that they have expanded their collaborative agreement to apply Aegis' patented Intravail(TM) drug delivery technology to intranasal heparin and beta-interferon.
Furthermore, Copaxone(R) is the only drug available for patients who do not benefit from or cannot tolerate beta-interferon.
4 billion global market in 1999, based on publicly reported sales data for its beta-interferon product, Rebif(r) (US$143 million), and three competing products.
As a widely accepted first-line therapy and the drug of choice for patients who do not benefit or cannot tolerate beta-interferon, Copaxone(R) is poised to gain its share rapidly.
The Multiple Sclerosis Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments, including beta-interferons, Copaxone, Novantrone, and Tysabri.

Full browser ?